JP2024507324A5 - - Google Patents

Info

Publication number
JP2024507324A5
JP2024507324A5 JP2023544229A JP2023544229A JP2024507324A5 JP 2024507324 A5 JP2024507324 A5 JP 2024507324A5 JP 2023544229 A JP2023544229 A JP 2023544229A JP 2023544229 A JP2023544229 A JP 2023544229A JP 2024507324 A5 JP2024507324 A5 JP 2024507324A5
Authority
JP
Japan
Prior art keywords
subject
pharmaceutical composition
administered
composition according
apraglutide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023544229A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507324A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/014349 external-priority patent/WO2022165204A1/en
Publication of JP2024507324A publication Critical patent/JP2024507324A/ja
Publication of JP2024507324A5 publication Critical patent/JP2024507324A5/ja
Pending legal-status Critical Current

Links

JP2023544229A 2021-01-28 2022-01-28 移植片対宿主病の治療のための組成物および方法 Pending JP2024507324A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163142905P 2021-01-28 2021-01-28
US63/142,905 2021-01-28
US202163248074P 2021-09-24 2021-09-24
US63/248,074 2021-09-24
PCT/US2022/014349 WO2022165204A1 (en) 2021-01-28 2022-01-28 Compositions and methods for the treatment of graft versus host disease

Publications (2)

Publication Number Publication Date
JP2024507324A JP2024507324A (ja) 2024-02-19
JP2024507324A5 true JP2024507324A5 (https=) 2025-02-05

Family

ID=80461100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023544229A Pending JP2024507324A (ja) 2021-01-28 2022-01-28 移植片対宿主病の治療のための組成物および方法

Country Status (11)

Country Link
US (3) US20240123036A1 (https=)
EP (2) EP4635509A1 (https=)
JP (1) JP2024507324A (https=)
KR (1) KR20230167019A (https=)
AU (1) AU2022212119A1 (https=)
BR (1) BR112023014978A2 (https=)
CA (1) CA3206093A1 (https=)
ES (1) ES3044110T3 (https=)
IL (1) IL304675A (https=)
MX (1) MX2023008793A (https=)
WO (1) WO2022165204A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025208047A1 (en) * 2024-03-28 2025-10-02 Vectivbio Ag Glucagon-like peptide 2 (glp-2) analogs for the treatment of graft versus host disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8421271B2 (en) * 2009-08-31 2013-04-16 General Electric Company Apparatus for transferring energy using onboard power electronics and method of manufacturing same
EP2314616A1 (en) 2009-10-23 2011-04-27 Ferring B.V. Peptidic GLP-2 agonists
CA3129576A1 (en) * 2019-02-11 2020-08-20 Opko Biologics Ltd. Long-acting glp-2 analogs
BR112022025141A2 (pt) 2020-06-09 2023-04-25 Vectivbio Ag Fabricação, formulação e dosagem de apraglutida

Similar Documents

Publication Publication Date Title
Gaze et al. Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma
Moertel et al. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group.
JP2022133453A (ja) 幹細胞移植方法
JP2004505009A (ja) 新生物を処置するための組合せ
JP2014500278A (ja) 二重特異性ｓｃＦｖコンジュゲートの投薬量および投与
Bearman et al. High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4–9 involved axillary lymph nodes
Zampino et al. Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer
Cummings Adjuvant radiation therapy for colorectal cancer
Di Xia et al. Mycophenolate mofetil as a successful therapy for idiopathic granulomatous mastitis
JP2024507324A5 (https=)
JP2014504636A (ja) 多形膠芽腫の治療のためのマシテンタンを含有する組み合わせ剤
Gopal et al. Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy
Appelbaum Optimising the conditioning regimen for acute myeloid leukaemia
Rowe Graft-versus-disease effect following allogeneic transplantation for acute leukaemia
Shibamoto et al. A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy
WO2023272831A1 (zh) 水苏糖在制备用于治疗去势抵抗性前列腺癌药物中的应用
Nachbaur et al. Polychemotherapy combined with G-CSF-mobilized donor buffy coat transfusion for granulocytic sarcoma after allogeneic BMT for AML
ES2371635T3 (es) Combinación de un derivado de diamida y agentes inmunosupresores para inhibir el rechazo de transplantes.
CN112773802B (zh) 一种化合物用于预防或治疗移植物抗宿主病的用途
Phillips Nasal chondrocytes enable cartilage repair in OA joints
Jacobs et al. A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group study
Sam et al. Sildenafil in dialysis patients
Nayak et al. Sirolimus-induced pneumonitis, sinusitis and macular oedema
Qazilbash et al. 19: Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma
Qazilbash et al. 20: Autologous stem cell transplantation for elderly patients with multiple myeloma